Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jessica B. Spinelli
Adaptive Reprogramming of De Novo Pyrimidine Synthesis Is a Metabolic Vulnerability in Triple-Negative Breast Cancer
Cancer Discovery
Oncology
Related publications
Histone Butyrylation/ Acetylation Remains Unchanged in Triple Negative Breast Cancer Cells After a Long Term Metabolic Reprogramming
Asian Pacific Journal of Cancer Prevention
Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
Frontiers in Oncology
Cancer Research
Oncology
Metabolic Consequences of HIF Silencing in a Triple Negative Human Breast Cancer Xenograft
Oncotarget
Oncology
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
Cell Reports
Biochemistry
Genetics
Molecular Biology
Triple-Negative Breast Cancer
Brachyury, a Vaccine Target, Is Overexpressed in Triple-Negative Breast Cancer
Endocrine-Related Cancer
Cancer Research
Endocrinology
Oncology
Metabolism
Diabetes
A Review of Triple-Negative Breast Cancer
Cancer Control
Medicine
Oncology
Hematology
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
Enzymatic De Novo Pyrimidine Nucleotide Synthesis
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry